A new study suggests that the common diabetes medication metformin may be considered for use in the prevention or treatment of ovarian cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that ovarian cancer patients who took the drug tended to live longer than patients who did not take it.
New treatments are desperately needed for ovarian cancer. Previous research has indicated that metformin, which originates from the French Lilac plant, may have anticancer properties. To look for an effect of the medication in ovarian cancer, Viji Shridhar, PhD, Sanjeev Kumar, MD, both of the Mayo Clinic in Rochester, MN, and their colleagues analyzed information from 61 patients with ovarian cancer who took metformin and 178 patients who did not.
Sixty-seven percent of those who took metformin had not died from ovarian cancer within five years, compared with 47 percent of those who did not take the medication. After accounting for factors such as cancer severity and patients' body mass index, the investigators found that patients taking metformin were 3.7 times more likely to survive throughout the study than those not taking it.
The findings demonstrate only a correlation between metformin intake and better survival, and additional studies are needed to decipher whether the observations made in this study represent a true beneficial effect of metformin in patients with ovarian cancer.
"This study opens the door for using metformin in large-scale randomized trials in ovarian cancer which can ultimately lead to metformin being one option for treatment of patients with the disease," said Dr. Shridhar. Such trials are currently underway in breast cancer. "We think that ovarian cancer research needs to follow that example," said Dr. Kumar.
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Instead of brooding over a failed relationship, psychologist advises a couple of aspirin and distancing oneself from the event
Brazilian researchers release thousands of mosquitoes infected with a bacteria that suppresses dengue fever into the environment in Rio de Janeiro.
Major food companies have cut trillions of calories, and studies show Americans are consuming fewer calories because of it. But some advocates think companies should do more to improve our diets.
The National Institutes of Health is providing $10 million to explore sex difference in disease, part of a move to boost female numbers in clinical trials
The World Health Organization warns of more than 20,000 cases by early November if help doesn't arrive quickly in West Africa. The CDC projects 1.4 million cases by late January.
When you're paid to hit people, it's not always easy to stop at the end of the work day—a fact the NFL has to reckon with, and fast
Is Democracy a key to better levels of health in a country? That's long been the belief, but we hear about some research that shows that isn't always the case.
You can learn a lot about people if you mess with their minds. Here are four infamous experiments in which psychologists gave in to unethical temptations
The number of people without enough to eat has fallen rapidly over the past 25 years, but sub-Saharan Africa and parts of Asia are still struggling
New research raises serious questions about how artificial sweeteners might affect our bodies, but let's keep our cool and just do more research